Reports from Stanford University Provide New Insights into Heart Failure (Pharmacovigilance Analysis of Heart Failure Associated With Anti-her2 Monotherapies and Combination Regimens for Cancer).

Předmět:	HEART failure FAILURE analysis DRUG side effects MONOCLONAL antibody biotechnology MONOCLONAL antibodies
Zdroj:	Women's Health Weekly; 4/18/2023, p721-721, 1p
Abstrakt:	Keywords: Palo Alto; State:California; United States; North and Central America; Antineoplastic Monoclonal Antibodies; Antineoplastics; Biotechnology; Breast Cancer; Cancer; Cardiology; Cardiovascular Diseases and Conditions; Drugs and Therapies; HER2 Inhibitors; Health and Medicine; Heart Disease; Heart Disorders and Diseases; Heart Failure; Immunologic Agents; Immunotherapy; Medical Devices; Monoclonal Antibodies; Oncology; Pertuzumab Therapy; Pharmaceuticals; Risk and Prevention; Trastuzumab Therapy; Tyrosine Kinase Inhibitors; Women's Health EN Palo Alto State:California United States North and Central America Antineoplastic Monoclonal Antibodies Antineoplastics Biotechnology Breast Cancer Cancer Cardiology Cardiovascular Diseases and Conditions Drugs and Therapies HER2 Inhibitors Health and Medicine Heart Disease Heart Disorders and Diseases Heart Failure Immunologic Agents Immunotherapy Medical Devices Monoclonal Antibodies Oncology Pertuzumab Therapy Pharmaceuticals Risk and Prevention Trastuzumab Therapy Tyrosine Kinase Inhibitors Women's Health 721 721 1 04/17/23 20230418 NES 230418 2023 APR 18 (NewsRx) -- By a News Reporter-Staff News Editor at Women's Health Weekly -- New research on Heart Disorders and Diseases - Heart Failure is the subject of a report. Heart failure (HF) risks from other anti-HER2 therapies are less clear.". [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu